Cargando…
STING mediates nuclear PD-L1 targeting-induced senescence in cancer cells
Immune checkpoint molecule programmed death-ligand 1 (PD-L1) is overexpressed in cancer cells and imparts resistance to cancer therapy. Although membrane PD-L1 has been targeted for cancer immune therapy, nuclear PD-L1 was reported to confer cancer resistance. Therefore, it is important to regulate...
Autores principales: | Lee, Je-Jung, Kim, So Young, Kim, Songhee H., Choi, Seoyeon, Lee, Bin, Shin, Jeon-Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477807/ https://www.ncbi.nlm.nih.gov/pubmed/36109513 http://dx.doi.org/10.1038/s41419-022-05217-6 |
Ejemplares similares
-
HMGB1 orchestrates STING-mediated senescence via TRIM30α modulation in cancer cells
por: Lee, Je-Jung, et al.
Publicado: (2021) -
Blockade of PD-L1/PD-1 signaling promotes osteo-/odontogenic differentiation through Ras activation
por: Jeon, So Mi, et al.
Publicado: (2022) -
Integrin-mediated adhesions in regulation of cellular senescence
por: Shin, Eun-Young, et al.
Publicado: (2020) -
STING mediates experimental osteoarthritis and mechanical allodynia in mouse
por: Shin, Youngnim, et al.
Publicado: (2023) -
Prognostic implications of PD-L1 expression in patients with angiosarcoma
por: Lee, Jii Bum, et al.
Publicado: (2021)